TP53 and breast cancer: These mutations may be localised in oncogenes and suppressor genes involved in carcinogenesis, such as Ras and p53. The obtained results confirmed that Ras mutation was identified in about 30% of BC cases, whereas the p53 mutation was observed in over 50% of BC patients14,15.